Pierson David J
Division of Pulmonary and Critical Care Medicine, Department of Medicine, Harborview Medical Center, Seattle, WA 98104, USA.
Respir Care. 2009 Jan;54(1):40-52.
Although noninvasive ventilation (NIV) was first used to treat patients with acute respiratory failure in the 1940s, the history of this mainstay of today's respiratory care armamentarium has mainly been written in the last 20 years. There is now a robust evidence base documenting the efficacy of NIV in exacerbations of chronic obstructive pulmonary disease, cardiogenic pulmonary edema, and acute respiratory failure in immunocompromised patients, and evidence in support of NIV in other settings, such as hypoxemic acute respiratory failure and the management of patients who decline endotracheal intubation, is accumulating rapidly. Efficacy as demonstrated in clinical trials does not necessarily translate to clinical effectiveness in practice, however, and important barriers need to be overcome if NIV is to realize for the average patient the potential it has shown in research studies. However, although the expansion of its use in everyday patient care has lagged behind the growth of its evidence base, an increasing number of studies document the steadily expanding use of NIV in the acute-care setting. This article reviews the history of NIV as applied in acutely ill patients and summarizes the studies of NIV outside the research setting during the last decade.
尽管无创通气(NIV)在20世纪40年代首次用于治疗急性呼吸衰竭患者,但当今呼吸护理设备这一主要手段的历史主要是在过去20年中书写的。现在有大量证据证明NIV在慢性阻塞性肺疾病急性加重、心源性肺水肿以及免疫功能低下患者的急性呼吸衰竭中的疗效,并且支持NIV在其他情况下应用的证据,如低氧性急性呼吸衰竭和拒绝气管插管患者的管理,正在迅速积累。然而,临床试验中所证明的疗效在实际应用中不一定能转化为临床效果,如果无创通气要为普通患者实现其在研究中所显示的潜力,还需要克服一些重要障碍。尽管其在日常患者护理中的应用扩展落后于证据基础的增长,但越来越多的研究记录了无创通气在急性护理环境中使用的稳步扩大。本文回顾了无创通气应用于急性病患者的历史,并总结了过去十年在研究环境之外对无创通气的研究。